Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

IM Cannabis Corp (CSE: IMCC )

3.740 UNCHANGED
Streaming Delayed Price Updated: 3:23 PM EST, Nov 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 98
Open 3.740
Bid (Size) 3.650 (100)
Ask (Size) 3.810 (500)
Prev. Close 3.740
Today's Range 3.740 - 3.740
52wk Range 0.2400 - 5.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3
International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue... 
Via Benzinga
Topics Cannabis Economy
Exposures Cannabis Supply Chain
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE:... 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
+769.77%
+769.77%
1 Month
+29.41%
+29.41%
3 Month
-5.79%
-5.79%
6 Month
+379.49%
+379.49%
1 Year
+523.33%
+523.33%

More News

Read More
The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
Via ACCESSWIRE
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel
Via ACCESSWIRE
IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Economy
Exposures Cannabis Supply Chain
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
IM Cannabis to Launch WAGNERS Brand in Germany
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Exposures COVID-19 Cannabis Legal
IMC Provides Further Details on Panaxia Transaction
From IM Cannabis Corp.
Via AccessWire
Topics Cannabis Intellectual Property Law Enforcement
Exposures COVID-19 Cannabis Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.